IMPACT BIOMEDICAL INC. (IBO)
About IMPACT BIOMEDICAL INC.
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $32.0K
- Net income
- -$11.8M
- Total assets
- $17.4M
- Market cap
- $61.1M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Operating income
- -$4.3M
- Income tax
- -$2.6M
- Net income
- -$11.9M
- EPS (basic)
- $-0.38
- EPS (diluted)
- $-0.38
Balance sheet
- Total assets
- $17.4M
- Current assets
- $411.0K
- Total liabilities
- $1.9M
- Current liabilities
- $1.2M
- Shareholders’ equity
- $15.6M
Cash flow
- Operating cash flow
- -$1.9M
- Investing cash flow
- $3.0K
- Financing cash flow
- -$109.0K
- Net cash flow
- -$2.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $61.1M
- EPS (diluted)
- $-0.38
- Shares outstanding
- 138.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 16, 2024
Impact Biomedical Inc. (IBO) Stock Price
- Reported a net loss of $11.8M in FY2025.
- Trading 73% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review IMPACT BIOMEDICAL INC..
Write a review
News about IMPACT BIOMEDICAL INC.
News & sentiment via Polygon.io
Impact Biomedical Inc.: frequently asked questions
Is Impact Biomedical Inc. an American company?
Impact Biomedical Inc. is a US-based company headquartered in Houston, Texas, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Impact Biomedical Inc. headquartered?
Impact Biomedical Inc. is headquartered in Houston, Texas, United States.
Is Impact Biomedical Inc. publicly traded?
Yes — Impact Biomedical Inc. is a publicly traded company. Its stock trades under the ticker symbol IBO on the NYSE.
What does Impact Biomedical Inc. do?
Impact Biomedical Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
